Fueled Crestor generic market preoccupied by CJ and Ildong
In the market of ‘Crestor(rosuvastatin),’ a hyperlipidemia treatment which was jumped in by approximately 50 pharmaceutical companies last year, CJ HealthCare and Ildong Pharmaceutical have succeeded in getting a head start.
The original Crestor has not been able to avoid sales struggle which wa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
